Allogeneic transplantation across major HLA barriers
- 31 December 2001
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 14 (4) , 741-754
- https://doi.org/10.1053/beha.2001.0170
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Transplantation of Megadoses of Purified Haploidentical Stem CellsAnnals of the New York Academy of Sciences, 1999
- Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA HaplotypeNew England Journal of Medicine, 1998
- Outcome of Cord-Blood Transplantation from Related and Unrelated DonorsNew England Journal of Medicine, 1997
- Use of Partially Mismatched Related Donors Extends Access to Allogeneic Marrow TransplantBlood, 1997
- Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.Journal of Clinical Oncology, 1997
- Use of stem cells from mismatched related donorsCurrent Opinion in Hematology, 1997
- COMBINED IN VITRO AND IN VIVO T LYMPHOCYTE DEPLETION FOR THE CONTROL OF GRAFT-VERSUS-HOST DISEASE FOLLOWING HAPLOIDENTICAL MARROW TRANSPLANTTransplantation, 1996
- Mismatched bone marrow transplantationCurrent Opinion in Oncology, 1995
- Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor ProgramNew England Journal of Medicine, 1993
- Marrow Transplantation from Related Donors Other Than HLA-Identical SiblingsNew England Journal of Medicine, 1985